Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
IFNLR1,Interferon lambda receptor 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26755,3545,1.24 [1.16-1.34],3.937150562235899e-09
IFNLR1,Interferon lambda receptor 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25738,833,1.45 [1.27-1.65],6.028649050479866e-08
IFNLR1,Interferon lambda receptor 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24893,974,1.44 [1.27-1.63],2.0226302713278784e-08
IFNLR1,Interferon lambda receptor 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27625,920,1.44 [1.27-1.64],1.9033646792547483e-08
IFNLR1,Interferon lambda receptor 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27510,805,1.45 [1.27-1.66],9.23788231495099e-08
IFNLR1,Interferon lambda receptor 1,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22547,32,2.63 [1.91-3.62],3.003389570541e-09
IFNLR1,Interferon lambda receptor 1,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22598,83,2.12 [1.63-2.76],1.8837997986796883e-08
IFNLR1,Interferon lambda receptor 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22671,156,2.01 [1.64-2.48],2.8213286563134608e-11
IFNLR1,Interferon lambda receptor 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27434,378,1.75 [1.48-2.05],1.6152093018698415e-11
IFNLR1,Interferon lambda receptor 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26718,3010,1.30 [1.21-1.40],1.7571498330155363e-11
IFNLR1,Interferon lambda receptor 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26823,4759,1.20 [1.12-1.28],3.0044724540784486e-08
IFNLR1,Interferon lambda receptor 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27248,1500,1.40 [1.26-1.55],1.6928382332906847e-10
IFNLR1,Interferon lambda receptor 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24941,7338,1.15 [1.09-1.21],9.04707875987584e-08
IFNLR1,Interferon lambda receptor 1,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27629,43,2.47 [1.78-3.41],4.7610989374277424e-08
IFNLR1,Interferon lambda receptor 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27543,612,1.59 [1.38-1.84],1.1332002684313878e-10
IFNLR1,Interferon lambda receptor 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27558,592,1.61 [1.40-1.86],6.62123547441547e-11
IFNLR1,Interferon lambda receptor 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19332,615,1.62 [1.41-1.87],2.752898966884892e-11
IFNLR1,Interferon lambda receptor 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [SjÂšgren],26831,161,2.00 [1.64-2.46],2.181434216290065e-11
IFNLR1,Interferon lambda receptor 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26893,223,2.00 [1.67-2.39],3.408430014293133e-14
IFNLR1,Interferon lambda receptor 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26656,1274,1.45 [1.30-1.61],2.8098927576955488e-11
IFNLR1,Interferon lambda receptor 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26885,1503,1.64 [1.50-1.79],1.3405034963934147e-27
IFNLR1,Interferon lambda receptor 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27543,2504,1.46 [1.35-1.58],2.6727378477610683e-22
